Detalhe da pesquisa
1.
Fracture Risk Assessment Tool-Based Screening for Osteoporosis in Older Adults in Resource-Limited Settings.
J Clin Densitom
; 27(3): 101494, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38677082
2.
Subclinical Hypothyroidism is Not Associated with Femoral Osteoporosis in Individuals Aged 50 Years or Older.
J Clin Densitom
; 26(2): 101362, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36967321
3.
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Cardiovasc Diabetol
; 21(1): 147, 2022 08 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35933413
4.
Intra-operative esmolol and pain following mastectomy: A randomised clinical trial.
Eur J Anaesthesiol
; 38(7): 735-743, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33831899
5.
Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity.
Nutr Metab Cardiovasc Dis
; 30(2): 254-264, 2020 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31753789
6.
DMARD-specific risk of atrial fibrillation in rheumatoid arthritis: a new piece in the puzzle.
Rheumatology (Oxford)
; 63(3): 591-593, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37740956
7.
Correction to: GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
Cardiovasc Diabetol
; 18(1): 23, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30823882
8.
GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data.
Cardiovasc Diabetol
; 17(1): 157, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545359
9.
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Health Econ Rev
; 13(1): 50, 2023 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37878108
10.
Risk factors of transplant renal artery stenosis in kidney transplant recipients.
Clinics (Sao Paulo)
; 77: 100087, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35931001
11.
Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.
Nutr Diabetes
; 11(1): 17, 2021 06 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34120150
12.
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years.
Diabetes Care
; 41(2): 364-367, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29180351
13.
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial.
Diabetes Metab
; 48(2): 101304, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34808345
14.
Total cholesterol and the risk of stroke: A double-edged sword or a blunt knife?
Atherosclerosis
; 270: 191-192, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29395097
15.
Response to Comment on de Carvalho et al. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years. Diabetes Care 2018;41:364-367.
Diabetes Care
; 41(4): e70-e71, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29559467
16.
Smoking-epigenetics interaction: What do microRNAs tell us about susceptibility to atherosclerotic disease in smokers?
Atherosclerosis
; 263: 309-310, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28592370
17.
Monthly PCSK9 inhibitors: The CHOICE for prolonged duration of effect.
Atherosclerosis
; 254: 300-302, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27745881